Wave Aspires To Accelerated Approval In DMD With 48-Week Data

 
• By Joseph Haas
  
DMD
Wave looks to accelerated approval for its Phase III Duchenne muscular dystrophy candidate • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Therapy Areas